By A study led by researchers from IGTP’s Immunology of Diabetes group has identified new microRNA as biomarkers for the partial remission phase, also known as “honeymoon phase,” of type 1 diabetes, and has linked the miR-30d-5p microRNA to immunoregulatory processes that may take place during this phase.
Studying partial remission of type 1 diabetes in children: New biomarkers and the immunoregulatory role of microRNA
Research scientist using digital tablet to browse internet and find biochemistry discovery. Female chemist working with device to create pharmaceutical cure, microbiology experiment.
Comments